Harlan F. Weisman

All filings by Harlan F. Weisman on record concern TFF Pharmaceuticals, Inc., in the capacity of board member. In total, 8 filings cover trades dated from 25 October 2019 to 3 July 2024.

No open-market sale appears; the market trades are 7 purchases worth €382k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.

Half of the purchases are above €24k and half below. Clusters matter here: 7 out of 7 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 8 July 2024, reports a share grant in TFF Pharmaceuticals, Inc. The clock since the last published purchase (15 August 2023) now reads 1,166 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.